[HTML][HTML] Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern
PR Wratil, M Stern, A Priller, A Willmann, G Almanzar… - Nature medicine, 2022 - nature.com
Infection-neutralizing antibody responses after severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection or coronavirus disease 2019 vaccination are an essential …
2 (SARS-CoV-2) infection or coronavirus disease 2019 vaccination are an essential …
[HTML][HTML] Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
…, S Schumacher, E Vogel, A Priller… - The Lancet Infectious …, 2021 - thelancet.com
The Oxford-AstraZeneca COVID-19 vaccine ChAdOx1 nCoV-19 is associated with a risk for
vaccineinduced immune thrombosis with thrombocytopenia syndrome in the range of one to …
vaccineinduced immune thrombosis with thrombocytopenia syndrome in the range of one to …
[HTML][HTML] Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
N Koerber, A Priller, S Yazici, T Bauer… - Nature …, 2022 - nature.com
Anti-viral immunity continuously declines over time after SARS-CoV-2 infection. Here, we
characterize the dynamics of anti-viral immunity during long-term follow-up and after …
characterize the dynamics of anti-viral immunity during long-term follow-up and after …
[HTML][HTML] Mild COVID-19 imprints a long-term inflammatory eicosanoid-and chemokine memory in monocyte-derived macrophages
…, F Henkel, A Quaranta, J Kolmert, A Priller… - Mucosal …, 2022 - Elsevier
Monocyte-derived macrophages (MDM) drive the inflammatory response to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and they are a major source of eicosanoids …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and they are a major source of eicosanoids …
[HTML][HTML] Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
…, A Hafkemeyer, D Ashok, A Hollaus, G Lupoli, A Priller… - Nature Cancer, 2023 - nature.com
Individuals with hematologic malignancies are at increased risk for severe coronavirus
disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity are …
disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity are …
[PDF][PDF] Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection
…, V Haselmann, M Neumaier, J Erber, A Priller… - Cell reports, 2022 - cell.com
T cell immunity is crucial for control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection and has been studied widely on a quantitative level. However, the …
infection and has been studied widely on a quantitative level. However, the …
[HTML][HTML] Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
E Vogel, K Kocher, A Priller, CC Cheng, P Steininger… - …, 2022 - thelancet.com
Background Vaccines are an important means to overcome the SARS-CoV-2 pandemic.
They induce specific antibody and T-cell responses but it remains open how well vaccine-…
They induce specific antibody and T-cell responses but it remains open how well vaccine-…
[HTML][HTML] Superior immunity that allows neutralization of all SARS-CoV-2 variants of concern develops in COVID-19 convalescents and naïve individuals after three …
U Protzer, P Wratil, M Stern, A Priller, A Willmann… - 2022 - europepmc.org
Infection-neutralizing antibody responses after SARS-CoV-2 infection or COVID-19 vaccination
are an essential part of antiviral immunity. This immune protection is challenged by the …
are an essential part of antiviral immunity. This immune protection is challenged by the …
Correction to: Mild COVID-19 imprints a long-term inflammatory eicosanoid-and chemokine memory in monocyte-derived macrophages
…, F Henkel, A Quaranta, J Kolmert, A Priller… - Mucosal …, 2022 - ncbi.nlm.nih.gov
The original version of this article contained an error in the ESM. The supplemental file titled
“Supplementary information 1” is a marked version of the correct file,“Supplementary …
“Supplementary information 1” is a marked version of the correct file,“Supplementary …
Recruitment of highly functional SARS-CoV-2-specific CD8+ T cell receptors mediating cytotoxicity of virus-infected target cells in non-severe COVID-19
…, V Haselmann, M Neumaier, J Erber, A Priller… - medRxiv, 2021 - medrxiv.org
T cell immunity is crucial for the control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections and has been widely characterized on a quantitative level. In …
infections and has been widely characterized on a quantitative level. In …